Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis

Overview of attention for article published in Breast Cancer Research, June 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 66 Dimensions

Readers on

mendeley: 75 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,119 followers.

RT @LGerratana: IL-6 and CCL5 pathways promote crosstalk between #TNBC and #lymphatic vessels and enhance of TNBC’s tumor growth and #metas…

19 May 2024

Reply Repost Favourite

IL-6 and CCL5 pathways promote crosstalk between #TNBC and #lymphatic vessels and enhance of TNBC’s tumor growth and #metastasis. Promising #preclinical results of the maraviroc (#CCR5 inhibitor) plus tocilizumab (anti-IL-6 receptor #antibody) combo #MBC h

26 Jun 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.